cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Bayu Brahma
Contact Email
journal.cancer@gmail.com
Phone
+628176389956
Journal Mail Official
admin@indonesianjournalofcancer.or.id
Editorial Address
National Cancer Center - Dharmais Cancer Hospital Research and Development Building, 3rd-floor Jl. Letjen S. Parman Kav. 84-86, Slipi West Jakarta
Location
Kota adm. jakarta barat,
Dki jakarta
INDONESIA
Indonesian Journal of Cancer
Published by National Cancer Center-Dharmais Cancer Hospital
ISSN : 19783744     EISSN : 23556811     DOI : https://www.doi.org/ 10.33371
Core Subject : Health, Science,
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health
Indonesian Journal of Cancer is a peer-reviewed and open-access journal. This journal is published quarterly (in March, June, September, and December) by Dharmais Cancer Hospital - National Cancer Center. Submissions are reviewed under a broad scope of topics relevant to experimental and clinical cancer research. Articles are original research that needs to be disseminated and written in English. All submitted manuscripts will go through the double-blind peer review and editorial review before being granted acceptance for publication. The journal publishes original research articles, case reports, and review articles under the following categories: cancer management, cancer prevention, cancer etiology, epidemiology, molecular oncology, cancer diagnosis and therapy, tumor pathology, surgical oncology, medical oncology, radiation oncology, interventional radiology, as well as early detection.
Arjuna Subject : Kedokteran - Onkologi
Articles 562 Documents
 50   51   52   53   54 
Reliability and Construct Validity of the Short Form 36 Questionnaire for Conjunctival Tumor Patients in Indonesia Indrakila, Senyum; Soewoto, Widyanti; Purnomo, Joko; Malindha, Erma; Prastawa, Reza Pahlevi
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1320

Abstract

Background: The Short Form 36 (SF-36) questionnaire was used to measure quality of life (QoL) in Indonesia for patients with various conditions. However, its validity and reliability, specifically for patients with conjunctival tumors, remain understudied. Given the limited research on health-related quality of life (HR-QoL) in this patient population, our research aims to fill this gap by validating the SF-36 specifically for conjunctival tumor patients. Method: This observational, cross-sectional study recruited patients with conjunctival tumors receiving treatment at the Department of Ophthalmology, Dr Moewardi Hospital, between May and July 2024, using consecutive sampling. Participants completed the SF-36 questionnaire in the Indonesian context. Validity was assessed through bivariate correlation analysis, examining the Pearson correlation value for each item's questionnaire with the total QoL score. Reliability was determined using scale reliability analysis, focusing on Cronbach's alpha coefficient. The data was processed using IBM SPSS version 26.Results: The Pearson correlation coefficients for the 36-item scores range from 0.345 to 0.797, indicating a moderate to significant correlation. The scale-level Cronbach's alpha for the comprehensive tool is 0.942, suggesting excellent internal consistency. The SF-36 demonstrated robust reliability across its eight domains, confirming its suitability for measuring QoL in this demographic. These findings confirm that the SF-36 questionnaire in the Indonesian context is highly reliable and has construct validity in conjunctival tumor patients.Conclusion: The SF-36 questionnaire in the Indonesian context exhibits a satisfactory reliability scale and construct validity in assessing the QoL of conjunctival tumor patients. Further research with a larger participant pool is recommended.
Correlations of Protein 53 (p53) Expression with the Degree of Tumor Budding in Cervical Carcinoma Wardana, Ni Komang Sara Kusuma; Armerinayanti, Ni Wayan; Cahyawati, Putu Nita
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1270

Abstract

Background: Cervical carcinoma is a malignant tumor that is most often found in the female reproductive system. Persistent Human Papillomavirus (HPV) infection is the most important factor in the development of cervical carcinoma. The E6 and E7 oncoproteins in HPV inhibit the action of p53. As a result, p53 transcription and the apoptosis process are inhibited. Tumor budding has been extensively studied and established as a significant prognostic factor. This study aims to determine the relationship between p53 expression and the degree of tumor budding of cervical carcinoma.Method: This cross-sectional study used 50 paraffin blocks and secondary data from patients diagnosed with cervical carcinoma stored at BaliMed Denpasar Hospital. Paraffin blocks were then subjected to immunohistochemical examination to evaluate p53 expression and HE examination to evaluate the degree of tumor budding. Data analysis was performed using the Spearman test and linear regression test with the SPSS 25 software program. Results: The results showed that thirty-two subjects had low expression of p53, and 62,5% of them had high-grade tumor budding. The p53 expression is lower in cervical cancer with highgrade tumor budding compared with low-grade tumor budding (rs = -0.33). There are significant correlations between p53 expression and the degree of tumor budding in patients with cervical carcinoma (p = 0.018). A total of 50 samples that met the inclusion and exclusion criteria were analyzed. The majority of patients were aged ≤ 50 years (58%) and had squamous cell carcinoma (90%) in the early stage (92%). Low p53 expression was found in 64% of samples. A significant negative correlation was found between p53 expression and tumor budding grade (p = 0.018; r = -0.333), which remained significant in multivariate analysis (p = 0.024; r² = -0.328), indicating that low p53 expression is associated with high-grade tumor budding. Conclusion: The p53 expression was significantly downregulated in cervical carcinoma with highgrade tumor budding. These findings indicate that tumor budding can be considered as a prognostic marker, but further research that sorts HPV dependent and HPV independent cervical carcinomas is needed.
Sensitivity and Specificity of Ultrasonography for Assessing Axillary Lymph Nodes in Breast Cancer Patients in Surakarta, Indonesia Bellynda, Monica; Yarso, Kristanto Yuli; Rosati, Ari; Kamil, Muhammad Rizki; Muhammad, Faizal
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1339

Abstract

Background: Breast cancer is the most common malignancy in women worldwide. Early detection is effective in reducing breast cancer mortality by 25–30%. Staging assessment with sentinel lymph node biopsy (SLNB) is the gold standard for patients with clinically negative axillae. Ultrasound examination of the axillae is often performed as a preoperative treatment for breast cancer patients to determine the stage of the cancer, where regional axillary lymph node assessment can be related to the prognostic factors of breast cancer, as well as assessing the prognosis for distant metastases. This study aims to evaluate the sensitivity of ultrasound examination of the axillary lymph nodes in breast cancer.Method: This study employs a descriptive research method with a retrospective approach, utilizing secondary data and comprising 283 samples. Inclusion criteria included patients diagnosed with cervical carcinoma confirmed by histopathological evaluation and complete medical records documenting age, primary complaints, histopathological classification, and TNM staging. Data were processed and presented using descriptive statistics. The study was conducted at the Surakarta Hospital between 2020 and 2022. Inclusion criteria were breast cancer patients with stage T1-2 N0 M0 confirmed by histopathological examination who underwent axillary lymph node ultrasound examination in Surakarta. Data was taken from the medical records. Patient's initial, age, date of examination, clinical diagnosis, expertise of the ultrasound, and histopathology of the axillary lymph node were recorded. The gold standard is SLNB. The calculation of diagnostic validity was carried out using a 2x2 table, and then the sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy of ultrasound were calculated.Results: 176 cases met the inclusion criteria, with 59.10% patients aged over 50 years old. Seventeen cases had positive ultrasound but negative histopathology examinations. Meanwhile, the remaining 15 cases had negative ultrasound but positive histopathology examinations. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and diagnostic accuracy results are as follows: 82%, 83%, 80%, 83%, 4.89, 0.21, and 82%, respectively.Conclusion: Ultrasound examination for assessing axillary lymph nodes is easy, inexpensive, effective, and safe. The results can be increased with better radiological methods and experience from higher-level operators.
Factors Related to the Quality of Life of Patients with Breast Cancer Undergoing Chemotherapy at Dharmais Cancer Hospital Mutiara, Septy; Yulianto, Sherly Putri; Shinta, Shinta; Marta, Shinta; Susilowati, Shinta; Masfufah, Dian Siti; Idu, Cicirosnita Jayadi; Ngasu, Kristina Everentia
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1331

Abstract

Background: Breast cancer is one of the most common cancers in the world, and patients commonly undergo chemotherapy. Chemotherapy adherence and other factors are associated with reduced quality of life (QoL) in patients with breast cancer. This study aimed to determine factors that influence the decreased QoL of breast cancer patients and the probability of reducing the QoL of patients with breast cancer.Method: A cross-sectional research design was employed with 159 respondents, using a purposive sampling technique. The criteria were patients with breast cancer undergoing chemotherapy, without experiencing decreased activity due to disability or respiratory disorders. The questionnaires were the Adolescent Scale Activity Questionnaire (ASAQ), chemotherapy compliance questionnaire, International Physical Activity Questionnaire (IPAQ), body image scale questionnaire, Malnutrition Screening Tool (MST), spiritual well-being scale (SWBS), and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Breast 23 (EORTC QLQ-BR23). Analysis was conducted using a chi-square test and a multivariate logistic regression. The research has been tested ethically by Dharmais Cancer Hospital.Results: Most patients with breast cancer undergoing chemotherapy at Dharmais Cancer Hospital were in the age category of ≤ 45 years (38.5%), secondary education or less (76.1%), unemployed (64.8%), and stage III (56.6%). The overall research results were sedentary behavior (OR=0.05, 95%CI:0.01-0.38), chemotherapy adherence (OR=9.94, 95%CI:2.12-46.57), daily physical activity (OR=5.65, 95%CI:1.21-26.40), body image (OR=20.44, 95%CI:2.59-161.61), and spiritual well-being (OR=10.78, 95%CI:2.86-40.57), identified as factors associated with QoL in patients with breast cancer. Meanwhile, the strength of the most significant relationship was high sedentary behavior (OR=9.10, SE: 1.16), and the smallest was low spiritual well-being (OR=0.07, SE: 1.03).Conclusion: We found that high sedentary behavior, non-compliant chemotherapy adherence, low daily physical activity, negative body image, and low spiritual well-being were related to decreased QoL in patients with breast cancer.
Simultaneous Presentation of Follicular Lymphoma and Diffuse Large B-cell lymphoma (DLBCL): A Case Report Handayani, Rosmeri; Kosasih, Agus Susanto
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1364

Abstract

Introduction: The natural history of follicular lymphoma (FL) is frequently characterized by transformation to a more aggressive diffuse large B-cell lymphoma (DLBCL). Outcomes of patients with histologic transformation (HT) of FL have been believed to be poor. However, a leucocytosis at presentation is infrequently described. In this report, we present a case of simultaneous presentation of follicular lymphoma and DLBCL.Case Presentation: A 50-year-old male patient presented to a head and neck specialist with complaints of slowly progressing swelling in the nose on the left side for a duration of 1 year, diagnosed with nasofarynx carcinoma. After excision surgery, the patient was referred to an internist for follow-up on the leukocytosis. Biopsy and immunohistochemistry from the nose and tonsil were suggestive of DLBCL. However, bone marrow aspiration was suggestive of follicular lymphoma. After a complete work-up, he was diagnosed with DLBCL and was treated with six cycles of the standard (CHOP) regimen. The patient’s history revealed a leukocytosis for 4 years prior to cardiac catheterization.Conclusion: These findings suggest a clonal relationship between the two types of lymphoma cells. Furthermore, they support the transformation of an acute follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma. Understanding the natural history of follicular lymphoma can aid the diagnosis and implies a worse prognosis in patients compared to de novo DLBCL.
Optimizing Malignant Pilomatricoma Management: The Role of Wide Excision and Adjuvant Radiation Saputra, Rudi; Ruslim, Samuel Kelvin; Hariyanto, Agustinus Darmadi; Setyorini, Yulita Pundewi; Pualillin, Elvis Deddy Kurniawan
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1347

Abstract

Introduction: Malignant pilomatricoma is a type of cancer that is rarely found. There are no standard guidelines for treating this condition. This study aims to evaluate the effectiveness of wide excision combined with adjuvant radiation therapy in optimizing the management of malignant pilomatricoma. Case Presentation: A 50-year-old male presented with a complaint of a growing mass on his head for the past four years. Subsequently, the patient underwent wide excision surgery and flap reconstruction. Based on histopathological examination, the mass was revealed to be a malignant pilomatricoma. Following this, the patient received radiation therapy using External Beam Radiation Therapy (EBRT) at a total dosage of 70 Gy over 35 sessions. The patient did not report any complaints during the 3-year follow-up.Conclusion: The combination of wide excision and adjuvant radiation therapy showed positive results in managing malignant pilomatricoma, with no recurrence or metastasis over three years of follow-up. These results suggest that radiation therapy may play a role in optimizing disease control after surgery. Further research is needed to establish more effective treatment guidelines
Exploring the Molecular and Cellular Aspects of Hydatidiform Mole: a Narrative Review Kusuma, Fitriyadi; Suryoadji, Kemal Akbar; As’syifa, Salsa Billa; Metasyah, Namira; Binathara, Geraldus Sigap Gung; Putra, Abdul Hafiidh Surya; Wulandari, Anisa Saphira
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1304

Abstract

Background: Hydatidiform mole, a type of gestational trophoblastic disease, arises from abnormal placental tissue and has the potential for malignant transformation. The condition’s incidence varies globally, with notable prevalence in Indonesia. Advanced maternal age, dietary factors, and a history of previous moles contribute to recurrence risks. Understanding the molecular and cellular mechanisms is critical for effective management.Methods: This narrative review synthesizes findings from primary studies and reviews exploring the molecular and cellular characteristics of hydatidiform mole. Data were sourced from Google Scholar, PubMed, and ScienceDirect using keywords like “hydatidiform mole,” “molecular mechanisms,” and “cell signaling pathways.”Results: The pathogenesis involves chromosomal abnormalities, particularly in complete moles characterized by a diploid genome lacking maternal DNA. P57KIP2 expression serves as a diagnostic marker, distinguishing complete from partial moles. Molecular genotyping, including short tandem repeat (STR) analysis, aids in accurate diagnosis and risk stratification for malignancy. Genetic factors, including mutations in NLRP7 and KHDC3L, are associated with recurrence in familial cases.Conclusion: The cellular and molecular insights into hydatidiform moles enhance understanding of their pathophysiology and inform diagnostic strategies. Recognizing genetic predispositions enables better patient management, emphasizing the need for continued research into the condition’s underlying mechanisms to improve clinical outcomes and therapeutic approaches.
Building Bridges in Cardio-Oncology: The Role of Clinics in Multidisciplinary Care and Patient Outcomes Laksono, Sidhi
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1299

Abstract

Cardio-oncology is a specialized field within cardiology that focuses on the relationship between cancer, its therapies, and cardiovascular health. This multidisciplinary domain, involving cardiology, hematology, and oncology, addresses the significant cardiovascular risks associated with cancer treatments, particularly chemotherapy, which can lead to conditions such as heart failure, coronary artery disease, myocarditis, and pericardial effusion. Developing robust clinical pathways is essential to mitigate these risks and ensure timely diagnosis and management of therapy-induced cardiac dysfunction. Cardio-oncology clinics play a pivotal role in integrating multidisciplinary expertise, providing consultation and heart evaluation services, and fostering research to improve patient outcomes. Strengthening collaboration across disciplines and raising awareness among patients are critical goals in advancing the effectiveness of cardio-oncology clinics.
Innovative Barcode Scan Media for Cancer Education: Empowering Parents of Children Undergoing Chemotherapy Faridah, Faridah; Mahyudin, Aulina; Setiadi, Setiadi; Kurniawan A, Zulkifli
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1384

Abstract

Background: Chemotherapy is a standard treatment for children with cancer, often accompanied by side effects such as nausea, vomiting, and hair loss. Parents require sufficient health education to manage their child’s treatment effectively. Previous methods lacked accessibility and engagement, which this study aims to address using digital technology. This study evaluates the impact of cancer treatment education using barcode scan media on the knowledge of parents with children undergoing chemotherapy at Dr. Soetomo Hospital. Method: This pre-experimental study used a one-group pretest-posttest design. A sample of 40 parents was selected via simple random sampling based on the following inclusion criteria: parents of children with cancer who were receiving chemotherapy, in good health, had provided informed consent, and owned an Android phone to access the barcode scan media. The exclusion criteria included parents who were ill or had children with complications. The intervention involved cancer treatment education through a barcode scan method, with knowledge measured using a questionnaire. Data were analysed using the Wilcoxon signed rank test, and SPSS software was used for statistical analysis.Results: Before the intervention, the mean knowledge score of parents was 7.65 (poor), which increased to 12.63 (good) after the intervention. The Wilcoxon signed-rank test showed a p-value of 0.000, indicating a statistically significant increase in parental knowledge. Conclusion: The study concluded that cancer treatment education through barcode scan media significantly improves parental knowledge regarding chemotherapy, offering a modern, accessible, and effective tool for health education. This method enhances understanding and management of chemotherapy side effects, leading to better child care outcomes.
Clinicopathologic Features of Carcinoma of the Cervix Uteri at Prof. Dr. I.G.N.G. Ngoerah Hospital in 2021-2022 Paramitha, Ni Made Laksmi Dewi; Dewi, I Gusti Ayu Sri Mahendra; Paskarani, Putu Erika; Winarti, Ni Wayan
Indonesian Journal of Cancer Vol 19, No 3 (2025): September
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i3.1328

Abstract

Background: Cervical cancer is a malignant tumor of the cervix with a high mortality rate, primarily identified by vaginal bleeding. Human papillomavirus (HPV) infection was found in 99.7% of cervical cancer cases. Other risk factors include age at first sexual intercourse, parity, smoking, weak immune system, use of oral contraceptives, and a high number of sexual partners. This study aims to analyze and describe the clinicopathological features of cervical carcinoma, including patient demographics, primary symptoms, histopathological types, and tumor staging, at Prof. Dr. I.G.N.G. Ngoerah Hospital from 2021 to 2022.Method: This study employs a descriptive research method with a retrospective approach, utilizing secondary data and comprising 283 samples. Inclusion criteria included patients diagnosed with cervical carcinoma confirmed by histopathological evaluation and complete medical records documenting age, primary complaints, histopathological classification, and TNM staging. Data were processed and presented using descriptive statistics. Results: The results showed that the age group with the highest number of cervical carcinoma cases was the 40-49 years age group (36.0%), the most common main complaint was bleeding (68.9%), the most common histopathological type was squamous cell carcinoma (78.8%), and the most common TNM stage was T1 (52 cases) and N0 (87 cases).Conclusion: This study highlights that cervical carcinoma predominantly affects women aged 40–49 years, with abnormal vaginal bleeding as the most common symptom. Squamous cell carcinoma was the most common histopathological type (78.8%), with the majority of cases staged at T1 (18.4%) and N0 (30.7%).

Page 52 of 57 | Total Record : 562

 50   51   52   53   54 

Filter by Year

2007 2025


Reset
Filter By Issues
All Issue Vol 19, No 3 (2025): September Vol 19, No 2 (2025): June Vol 19, No 1 (2025): March Vol 18, No 4 (2024): December Vol 18, No 3 (2024): September Vol 18, No 2 (2024): June Vol 18, No 1 (2024): March Vol 17, No 4 (2023): December Vol 17, No 3 (2023): September Vol 17, No 2 (2023): June Vol 17, No 1 (2023): March Vol 16, No 4 (2022): December Vol 16, No 3 (2022): September Vol 16, No 2 (2022): June Vol 16, No 1 (2022): March Vol 15, No 4 (2021): December Vol 15, No 3 (2021): September Vol 15, No 2 (2021): June Vol 15, No 1 (2021): March Vol 14, No 4 (2020): December Vol 14, No 3 (2020): September Vol 14, No 2 (2020): June Vol 14, No 1 (2020): March Vol 13, No 4 (2019): December Vol 13, No 3 (2019): September Vol 13, No 2 (2019): June Vol 13, No 1 (2019): March Vol 12, No 4 (2018): October-December Vol 12, No 3 (2018): July-September Vol 12, No 2 (2018): April-June Vol 12, No 1 (2018): Jan - Mar Vol 11, No 4 (2017): October- December 2017 Vol 11, No 3 (2017): July - September 2017 Vol 11, No 2 (2017): April - June Vol 11, No 1 (2017): Jan-Mar Vol 10, No 4 (2016): October - December 2016 Vol 10, No 3 (2016): July - September 2016 Vol 10, No 2 (2016): April - June 2016 Vol 10, No 1 (2016): Jan - Mar 2016 Vol 9, No 4 (2015): Okt - Des 2015 Vol 9, No 3 (2015): Jul - Sept 2015 Vol 9, No 2 (2015): April-Juni 2015 Vol 9, No 1 (2015): Jan - Mar 2015 Vol 8, No 4 (2014): Oct - Dec 2014 Vol 8, No 3 (2014): Jul - Sep 2014 Vol 8, No 2 (2014): April-Juni 2014 Vol 8, No 1 (2014): Jan - Mar 2014 Vol 7, No 4 (2013): Oct - Dec 2013 Vol 7, No 3 (2013): Jul - Sep 2013 Vol 7, No 2 (2013): Apr - Jun 2013 Vol 7, No 1 (2013): Jan - Mar 2013 Vol 6, No 4 (2012): Oct - Dec 2012 Vol 6, No 3 (2012): Jul - Sep 2012 Vol 6, No 2 (2012): Apr - Jun 2012 Vol 6, No 1 (2012): Jan - Mar 2012 Vol 5, No 4 (2011): Oct - Dec 2011 Vol 5, No 3 (2011): Jul - Sep 2011 Vol 5, No 2 (2011): Apr - Jun 2011 Vol 5, No 1 (2011): Jan - Mar 2011 Vol 4, No 4 (2010): Oct - Dec 2010 Vol 4, No 3 (2010): Jul - Sep 2010 Vol 4, No 2 (2010): Apr - Jun 2010 Vol 4, No 1 (2010): Jan - Mar 2010 Vol 3, No 4 (2009): Oct - Dec 2009 Vol 3, No 3 (2009): Jul - Sep 2009 Vol 3, No 2 (2009): Apr - Jun 2009 Vol 3, No 1 (2009): Jan - Mar 2009 Vol 2, No 4 (2008): Oct - Dec 2008 Vol 2, No 3 (2008): Jul - Sep 2008 Vol 2, No 2 (2008): Apr - Jun 2008 Vol 2, No 1 (2008): Jan - Mar 2008 Vol 1, No 4 (2007): Oct - Dec 2007 Vol 1, No 3 (2007): Jul - Sep 2007 Vol 1, No 2 (2007): Apr - Jun 2007 Vol 1, No 1 (2007): Jan - Mar 2007 More Issue